Navamedic ASA Cash Flow Conversion Efficiency
Navamedic ASA cash flow conversion efficiency. Based on the latest financial reports, Navamedic ASA (NAVA) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr5.69 Million ≈ $598.86K USD) by net assets (Nkr306.09 Million ≈ $32.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Navamedic ASA (2003–2025)
Cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. This chart illustrates how Navamedic ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NAVA stock price for real-time trading data and today's change.
Navamedic ASA Cash Flow Conversion Ratio Explained
Navamedic ASA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Navamedic ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Navamedic ASA ranked by their cash flow conversion efficiency. Also see Navamedic ASA market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Epitomee Medical Ltd
TA:EPIT
|
-0.416x |
|
Pasdec Holdings Bhd
KLSE:6912
|
-0.022x |
|
TPC Mechatronics Corporation
KQ:048770
|
-0.010x |
|
Profoto Holding AB
ST:PRFO
|
0.022x |
|
Beyaz Filo Oto Kiralama AS
IS:BEYAZ
|
0.347x |
|
MicroAlgo Inc.
NASDAQ:MLGO
|
0.006x |
|
ML System S.A.
WAR:MLS
|
-0.076x |
|
Apollo Power Ltd
TA:APLP
|
-0.100x |
Annual Cash Flow Conversion Efficiency for Navamedic ASA (2003–2025)
The table below shows the annual cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. Review Navamedic ASA (NAVA) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr334.08 Million ≈ $35.15 Million |
Nkr25.59 Million ≈ $2.69 Million |
0.077x | -53.21% |
| 2024-12-31 | Nkr240.44 Million ≈ $25.30 Million |
Nkr39.35 Million ≈ $4.14 Million |
0.164x | +1570.51% |
| 2023-12-31 | Nkr222.39 Million ≈ $23.40 Million |
Nkr2.18 Million ≈ $229.29K |
0.010x | -88.55% |
| 2022-12-31 | Nkr209.72 Million ≈ $22.07 Million |
Nkr17.94 Million ≈ $1.89 Million |
0.086x | +1095.23% |
| 2021-12-31 | Nkr151.24 Million ≈ $15.91 Million |
Nkr-1.30 Million ≈ $-136.80K |
-0.009x | +65.00% |
| 2020-12-31 | Nkr129.49 Million ≈ $13.63 Million |
Nkr-3.18 Million ≈ $-334.63K |
-0.025x | -115.29% |
| 2019-12-31 | Nkr79.23 Million ≈ $8.34 Million |
Nkr12.72 Million ≈ $1.34 Million |
0.161x | +144.27% |
| 2018-12-31 | Nkr99.32 Million ≈ $10.45 Million |
Nkr-36.02 Million ≈ $-3.79 Million |
-0.363x | -159.37% |
| 2017-12-31 | Nkr96.70 Million ≈ $10.18 Million |
Nkr59.07 Million ≈ $6.22 Million |
0.611x | +545.20% |
| 2016-12-31 | Nkr105.73 Million ≈ $11.13 Million |
Nkr-14.51 Million ≈ $-1.53 Million |
-0.137x | -171.72% |
| 2015-12-31 | Nkr118.28 Million ≈ $12.45 Million |
Nkr22.63 Million ≈ $2.38 Million |
0.191x | +297.98% |
| 2014-12-31 | Nkr111.23 Million ≈ $11.70 Million |
Nkr-10.75 Million ≈ $-1.13 Million |
-0.097x | +33.78% |
| 2013-12-31 | Nkr107.26 Million ≈ $11.29 Million |
Nkr-15.65 Million ≈ $-1.65 Million |
-0.146x | -117.92% |
| 2012-12-31 | Nkr96.68 Million ≈ $10.17 Million |
Nkr-6.47 Million ≈ $-681.19K |
-0.067x | -6435.86% |
| 2011-12-31 | Nkr93.24 Million ≈ $9.81 Million |
Nkr-95.52K ≈ $-10.05K |
-0.001x | +99.24% |
| 2010-12-31 | Nkr100.21 Million ≈ $10.54 Million |
Nkr-13.46 Million ≈ $-1.42 Million |
-0.134x | -811.95% |
| 2009-12-31 | Nkr111.78 Million ≈ $11.76 Million |
Nkr-1.65 Million ≈ $-173.31K |
-0.015x | +84.76% |
| 2008-12-31 | Nkr110.24 Million ≈ $11.60 Million |
Nkr-10.66 Million ≈ $-1.12 Million |
-0.097x | -324.44% |
| 2007-12-31 | Nkr128.99 Million ≈ $13.57 Million |
Nkr5.56 Million ≈ $584.83K |
0.043x | +124.42% |
| 2006-12-31 | Nkr60.87 Million ≈ $6.40 Million |
Nkr-10.74 Million ≈ $-1.13 Million |
-0.176x | -144.73% |
| 2005-12-31 | Nkr43.19 Million ≈ $4.54 Million |
Nkr-3.11 Million ≈ $-327.70K |
-0.072x | +62.10% |
| 2004-12-31 | Nkr19.03 Million ≈ $2.00 Million |
Nkr-3.62 Million ≈ $-381.04K |
-0.190x | +68.79% |
| 2003-12-31 | Nkr7.21 Million ≈ $758.70K |
Nkr-4.40 Million ≈ $-462.53K |
-0.610x | -- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more